Phase I, Drug-drug Interaction Study of the Inhibition Potential of KL1333 in Healthy Subjects
Condition: Mitochondrial Disease Interventions: Drug: KL1333; Drug: Flurbiprofen; Drug: Dextromethorphan; Drug: Bupropion; Drug: Midazolam injection; Drug: Omeprazole; Drug: Caffeine; Drug: Repaglinide Sponsor: Abliva AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2020 Category: Research Source Type: clinical trials
Drug-drug Interaction Study of KL1333 in Healthy Subjects
Condition: Mitochondrial Disease Interventions: Drug: KL1333; Drug: Flurbiprofen; Drug: Dextromethorphan; Drug: Bupropion; Drug: Midazolam injection; Drug: Omeprazole; Drug: Caffeine; Drug: Repaglinide Sponsor: Abliva AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2020 Category: Research Source Type: clinical trials